Baird Financial »

Dyne Therapeutics shares owned by Baird Financial

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Baird Financial from 13F filings

Historical chart of Baird Financial investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Baird Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Baird Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 103k 19.56

More positions owned by Baird Financial

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Jpmorgan Chase Common (JPM)
Alphabet Inc Cap Stk Cl C Common (GOOG)
Berkshire Hathaway Inc Del Cl B Common (BRK.B)
Ishares Tr Rus 1000 Grw Etf Common (IWF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt Common (VEA)
Ishares Tr Rus 1000 Val Etf Common (IWD)
Ge Aerospace Common (GE)
Meta Platforms Inc Cl A Common (META)
Ge Vernova Common (GEV)
Amazon Common (AMZN)
Home Depot Common (HD)
Johnson Johnson Common (JNJ)
Nvidia Corporation Common (NVDA)

View all positions for Baird Financial

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
Vanguard Group
BlackRock
Atlas Venture Life Science Advisors
State Street Corporation
Fcpm Iii Services B.v.
FMR
Orbis Allan Gray
TCG Crossover Management
Adage Capital Partners GP
Siren
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management

View all funds holding Dyne Therapeutics